Clinical Trial Update: Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on using human menstrual blood-derived mesenchymal stem cells to treat liver cirrhosis (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• Human menstrual blood-derived mesenchymal stem cells

Snippet

Sponsor: S-Evans Biosciences Co., Ltd. | Conditions: Liver Cirrhosis, Fibrosis | Phase 1, Phase 2 | Status: UNKNOWN